Tissue Imaging Market Size To Be Worth USD 27.32 Billion by 2027 | Emergen Research

Vancouver, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The Global Tissue Imaging Market is projected to be worth USD 27.32 Billion by 2027, according to the current analysis by Emergen Research. The tissue imaging market is observing high demand attributed to the growing incidence of infectious diseases. Emerging infectious diseases pose a substantial burden on public health and economies worldwide and are considered to be triggered essentially by socio-economic, ecological, and environmental factors. The outbreak of the COVID-19 pandemic has dramatically raised cognizance of the worldwide burden of infectious disease and about the readiness of public health systems to combat the spread of such diseases.

Increased funding for research and development of antimicrobial susceptibility testing is a crucial factor driving the tissue imaging market demand. In February 2020, Becton, Dickinson, and Company made an announcement about a USD 6.0 million agreement with the Fleming Fund, a program by the Department of Healthcare and Social Care in the U.K. that aids low- and middle-income nations worldwide to tackle antimicrobial resistance. Becton, Dickinson, and Company, through this contract, will offer diagnostic/imaging apparatus and informatics solutions to assist in infection diagnosis and help physicians deliver suitable antimicrobial prescriptions.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample-form/362

Key Highlights From The Report

• In May 2020, Bio-Rad Laboratories, Inc. introduced the GelDoc Go Imaging System, designed for documenting protein colorimetric bolts, gels & nucleic acids, and stain-free gels & bolts.
• Immunofluorescence staining held a significant tissue imaging market share in 2019 and deploys cultured cell lines or tissue sections as a source of antigen and identifies particular recognition of autoantibodies to native autoantigens present on fixed tissue/cell. The availability of several antigenic targets offers exceptional complete sensitivity.
• Direct visualization/imaging of diseased tissues is beneficial in recognizing patients at high cardiovascular complication risks, enabling doctors to offer customized risk-based treatment.
• The tissue imaging market dominance of the North American region is due to the increasing incidences of cancer, increased funding for research and development activities, growing demand for customized medicine, proteomics research technological progressions, and the presence of key tissue imaging firms in the region.
• Key participants include Abcam PLC, Bio-Rad Laboratories, Becton, Dickinson, and Company, Fluidigm Corporation, Abbott Laboratories, Agilent Technologies, Biocare Medical, Danaher Corporation, F. Hoffmann-La Roche Ltd., and Nikon Corporation, among others.

ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.emergenresearch.com/select-license/362

Emergen Research has segmented the Global Tissue Imaging Market on the basis of technology, product, application, end-user, and region:

• Technology Outlook (Revenue, USD Billion; 2017-2027)
  • Mass Spectroscopy
  • Immunohistochemistry
  • Flow Cytometry
  • Digital Pathology
  • In Situ Hybridization
  • Immunofluorescence
  • Others
• Product Outlook (Revenue, USD Billion; 2017-2027)
  • Platforms
  • Microscopes
  • Consumables
  • Software
  • Accessories
• Application Outlook (Revenue, USD Billion; 2017-2027)
  • Disease Research
    1. Oncology Research
    2. Infectious Diseases Research
    3. Neurological Disease Research
    4. Cardiovascular Disease Research
    5. Immunological Disease Research
    6. Others
  • Diagnostics
    1. Oncology Diagnostics
    2. Infectious Diseases Diagnostics
    3. Neurological Disease Diagnostics
    4. Cardiovascular Disease Diagnostics
    5. Immunological Disease Diagnostics
    6. Others
• End-User Outlook (Revenue, USD Billion; 2017-2027)
  • Hospitals & Clinics
  • Pharmaceutical Companies
  • Research Institutes
  • Others

To identify the key trends in the industry and read full summary click on the link:   https://www.emergenresearch.com/industry-report/tissue-imaging-market

• Regional Outlook (Revenue, USD Billion; 2017-2027)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. U.K.
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. U.A.E.
    3. Rest of MEA

Take a Look at our Related Reports:

In Silico Drug Discovery Market By Workflow (Discovery, Preclinical Tests, Clinical Trials), By Product (Consultancy as a Service, Software as a Service), By Type of Large Molecule, By End User (Contract Research Organizations, Pharmaceutical Industry), and By Region, Forecasts to 2027

Human Microbiome Modulators Market By Product (Prebiotics and Dietary Supplements, Probiotics and Creams, Drugs), By Application (Infections, Neurological Disorders, Cancers, Dermatological, Gastrointestinal, Metabolic), By Region Forecasts to 2027

Intelligent Drug Discovery Market By Offering (Software, Services), By Technology (Machine Learning, Other Technologies), By Application (Neurodegenerative Diseases, Metabolic Diseases, Immuno-Oncology), By End User (Contract Research Organizations), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-tissue-imaging-market